| CAR T cells administered in combination with lymphodepletion and PD-1 inhibition to patients with neuroblastoma A Heczey, CU Louis, B Savoldo, O Dakhova, A Durett, B Grilley, H Liu, ... Molecular therapy 25 (9), 2214-2224, 2017 | 486 | 2017 |
| Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy A Heczey, D Liu, G Tian, AN Courtney, J Wei, E Marinova, X Gao, L Guo, ... Blood, The Journal of the American Society of Hematology 124 (18), 2824-2833, 2014 | 292 | 2014 |
| Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis A Heczey, AN Courtney, A Montalbano, S Robinson, K Liu, M Li, ... Nature medicine 26 (11), 1686-1690, 2020 | 205 | 2020 |
| Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups P Sumazin, Y Chen, LR Treviño, SF Sarabia, OA Hampton, K Patel, ... Hepatology 65 (1), 104-121, 2017 | 202 | 2017 |
| Glypican-3–specific CAR T cells coexpressing IL15 and IL21 have superior expansion and antitumor activity against hepatocellular carcinoma SA Batra, P Rathi, L Guo, AN Courtney, J Fleurence, J Balzeau, RS Shaik, ... Cancer immunology research 8 (3), 309-320, 2020 | 186 | 2020 |
| CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo G Tian, AN Courtney, B Jena, A Heczey, D Liu, E Marinova, L Guo, X Xu, ... The Journal of clinical investigation 126 (6), 2341-2355, 2016 | 158 | 2016 |
| IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity D Liu, L Song, J Wei, AN Courtney, X Gao, E Marinova, L Guo, A Heczey, ... The Journal of clinical investigation 122 (6), 2221-2233, 2012 | 152 | 2012 |
| NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma X Xu, W Huang, A Heczey, D Liu, L Guo, M Wood, J Jin, AN Courtney, ... Clinical Cancer Research 25 (23), 7126-7138, 2019 | 145 | 2019 |
| Redirecting T cells to glypican-3 with 4-1BB zeta chimeric antigen receptors results in Th1 polarization and potent antitumor activity W Li, L Guo, P Rathi, E Marinova, X Gao, MF Wu, H Liu, G Dotti, ... Human gene therapy 28 (5), 437-448, 2017 | 105 | 2017 |
| Undifferentiated embryonal sarcoma of the liver (UESL): a single-center experience and review of the literature P Techavichit, PM Masand, RW Himes, R Abbas, JA Goss, SA Vasudevan, ... Journal of Pediatric Hematology/Oncology 38 (4), 261-268, 2016 | 76 | 2016 |
| Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ... Nature Medicine 29 (6), 1379-1388, 2023 | 59 | 2023 |
| Health disparities are important determinants of outcome for children with solid tumor malignancies MT Austin, H Nguyen, JM Eberth, Y Chang, A Heczey, DP Hughes, ... Journal of pediatric surgery 50 (1), 161-166, 2015 | 56 | 2015 |
| Advances in chimeric antigen receptor immunotherapy for neuroblastoma A Heczey, CU Louis Discovery medicine 16 (90), 287, 2013 | 51 | 2013 |
| Targeting the tumor microenvironment using manipulated nkt cells LS Metelitsa, D Liu, G Dotti, A Heczey US Patent App. 14/345,394, 2014 | 45 | 2014 |
| Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation K Haines, SF Sarabia, KR Alvarez, G Tomlinson, SA Vasudevan, ... Pediatric blood & cancer 66 (7), e27745, 2019 | 36 | 2019 |
| T cell-activating mesenchymal stem cells as a biotherapeutic for HCC A Szoor, A Vaidya, MP Velasquez, Z Mei, DL Galvan, D Torres, A Gee, ... Molecular Therapy-Oncolytics 6, 69-79, 2017 | 36 | 2017 |
| Targeting O‐Acetyl‐GD2 Ganglioside for Cancer Immunotherapy J Fleurence, S Fougeray, M Bahri, D Cochonneau, B Clémenceau, ... Journal of immunology research 2017 (1), 5604891, 2017 | 35 | 2017 |
| Vascular invasion is a prognostic indicator in hepatoblastoma Y Shi, SJ Commander, PM Masand, A Heczey, JA Goss, SA Vasudevan Journal of Pediatric Surgery 52 (6), 956-961, 2017 | 30 | 2017 |
| Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults P Sumazin, TL Peters, SF Sarabia, HR Kim, M Urbicain, EF Hollingsworth, ... Journal of Hepatology 77 (4), 1026-1037, 2022 | 28 | 2022 |
| Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States JA Kahla, DA Siegel, S Dai, PJ Lupo, JH Foster, ME Scheurer, AA Heczey Pediatric blood & cancer 69 (10), e29763, 2022 | 26 | 2022 |
Helen HeslopCenter for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas在 bcm.edu 的电子邮件经过验证
